Has done well in all areas : increasing revenue, increasing sales, improving merging and and becoming EBIT positive. YFZ still has $39m in cash from IPO to implement new improvements and grow. Below are key highlights:
EBITDA for H1 FY2021 of $0.5million, vs H1 FY2020 of $1.7million (and H2 FY2020 EBITDA loss of $(4.4) million)
Reported NPAT for H1 FY2021 of $2.5 million, vs a loss in pcp of $(1.9) million
Well capitalised following IPO, with cash at bank of $39.0 million as at 25 December 2020 (net cash of $35.0 million)
FY2021 gross revenue up 16.5% vs pcp to $100.0 million.
H1 FY2021 net revenue up 15.3% vs pcp to $73.4
Gross profit margin for H1 FY2021 of 31.9%, up 1.5% vs pcp
YFZ Price at posting:
95.5¢ Sentiment: Buy Disclosure: Held
